Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 463)
Posted On: 02/05/2021 12:03:23 AM
Post# of 153903
Posted By: chazzledazzle
Re: chazzledazzle #76345
The Chinese CRISPR-cas9 twins as an example...

"If one does not have CCR5 is the angiogenesis effect void?"

The following question is not about angiogenesis but rather bodies that don't express CCR5 on their immune cells at all.

The Chinese gene-edited twins are a petri dish example. The allele delta 32 mutants of the descendants of plague survivors, if I'm saying that correctly, I believe fall into the category of not possessing the CCR5 receptors on immune cell membranes.

Question: Does Leronlimab have a purpose or an effect in the cohort of people that do not express CCR5 receptors at all?

Follow-up Question: Do any of the LL MOAs that are unrelated to CCR5 still have revelance in the cohort of people that do not express CCR5 receptors?

Don't worry, I'm all in on CYDY - believe it. And this is a relatively small cohort. But it's what I think about while walking my dog.













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site